Suchergebnisse - "Nahar, Kazi J"

PubPharm (5)

1

Stroma-infiltrating T cell spatiotypes define immunotherapy outcomes in adolescent and young adult patients with melanoma

enthalten in: Nature communications | 2024

von Bai, X. | Attrill, G. | Gide, T. | +12

2

Management of infliximab refractory immune checkpoint inhibitor gastrointestinal toxicity : a multicenter case series

enthalten in: Journal for immunotherapy of cancer | 2024

von Harvey, C. | Nahar, K. | McKeown, J. | +19

3

Distinct pretreatment innate immune landscape and posttreatment T cell responses underlie immunotherapy-induced colitis

enthalten in: JCI insight | 2022

von Nahar, K. | Marsh-Wakefield, F. | Rawson, R. | +15

CommentIn: Immunol Cell Biol. 2023 Jan;101(1):12-15. - PMID 36326611

4

Higher proportions of CD39+ tumor-resident cytotoxic T cells predict recurrence-free survival in patients with stage III melanoma treated with adjuvant immunotherapy

enthalten in: Journal for immunotherapy of cancer | 2022

von Attrill, G. | Owen, C. | Ahmed, T. | +13

5

Clinicopathological characteristics and management of colitis with anti-PD1 immunotherapy alone or in combination with ipilimumab

enthalten in: Journal for immunotherapy of cancer | 2020

von Nahar, K. | Rawson, R. | Ahmed, T. | +9

1
[1]